Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC
(MedPage Today) -- An investigational therapeutic vaccine appeared to be effective in delaying relapse of KRAS-mutated pancreatic and colorectal cancer (CRC), according to results from the phase I AMPLIFY-201 study.
Among 25 patients with pancreatic...
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Colorectal Cancer | Gastroenterology | Pancreas | Pancreatic Cancer | Study | Vaccines